Articles related to GLYCEMIC CONTROL

SGLT-2 inhibitors have emerged as a cornerstone in managing HFrEF and CKD, demonstrating substantial reductions in cardiovascular and renal adverse outcomes. This class of medications is reshaping the therapeutic approach in patients with these comorbid conditions, providing a dual benefit that was once considered challenging to achieve.

Understanding the dietary interactions with metformin is essential for healthcare providers to maximize the drug’s efficacy in Type 2 diabetes management. Tailoring diet recommendations can significantly influence patient outcomes and drug tolerance.

GLP-1 agonists are increasingly recognized for their dual benefits in type 2 diabetes management and cardiovascular risk reduction, offering a multifaceted approach to patient care in an expanding global market.

This article illustrates a case of bullosis diabeticorum, spotlighting the condition’s clinical presentation, diagnosis, and management, offering key insights for physicians in the early detection and care of this rare diabetic complication.

Stevia’s interaction with the liver and potential effects on gut microbiome composition highlight the complexity of its impact on human health, reinforcing the importance of a nuanced approach when recommending dietary choices.

In the management of diabetes, the timing of exercise plays a crucial role, with postprandial activity shown to effectively lower post-meal hyperglycemia and contribute to better overall glycemic control.